Atlas Trials

Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

Clinical trial NCT02497404 · COMPLETED

Trial details

NCT number
NCT02497404
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia, Erythroblastic, AcuteMyelodysplastic Syndromes
Start date
2015-02-13
Primary completion
2020-06-17
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.